Who is on it, and how far along Every drug ChEMBL records acting on OPRD1, by the furthest stage it has reached for any use, coloured by modality.
How to read this Each mark is one drug. Columns run from approved to phase 1; hover or tap a mark for its sponsor, modality and open trials, and click it to open the drug.
Approved8 Naloxone Naloxone SponsorADAPT ModalitySmall molecule ActionAntagonist Open trials104 Naltrexone Naltrexone SponsorClive Michelsen ModalitySmall molecule ActionAntagonist Open trials63 Codeine Codeine SponsorHikma Pharmaceuticals ModalitySmall molecule ActionAgonist Open trials51 Nalbuphine Nalbuphine SponsorPH Health ModalitySmall molecule ActionAgonist Open trials37 Hydrocodone Hydrocodone SponsorMerck & Co. (MSD) ModalitySmall molecule ActionAgonist Open trials23 Oxymorphone Oxymorphone SponsorEndo International ModalitySmall molecule ActionAgonist Open trials3 Benzhydrocodone Benzhydrocodone SponsorNot known ModalitySmall molecule ActionAgonist Open trials0 Dextromoramide Dextromoramide SponsorNot known ModalitySmall molecule ActionAgonist Open trials0 Phase 31 Cebranopadol Cebranopadol SponsorAdneuris Therapeutics, Inc. ModalitySmall molecule ActionAgonist Open trials2 Phase 21 Ondelopran Ondelopran SponsorEli Lilly ModalitySmall molecule ActionAntagonist Open trials0
Every drug acting on it, furthest along first. The sponsor is the US application holder where there is one, else the industry lead sponsor of most of its registered trials. 7 of 10 act as: Opioid receptors; mu/kappa/delta agonist; the rest name their own mechanism. The most recently posted recruiting or ongoing trials naming each drug (up to 8 a drug), 40 in all, from ClinicalTrials.gov. Trial Drug Phase Status Lead sponsor First posted A Study of the Potential Pharmacokinetic Interaction Between Quinidine Sulfate and Nalbuphine Extended-Release Tablets (NAL ER) in Healthy Participants Nalbuphine Phase 1 Recruiting Trevi Therapeutics Nov 18, 2026 Effectiveness of Phenotype-based Pain Management Guidelines for Head and Neck Cancer Related Pain: a Pilot Study Codeine Phase 2 Recruiting Shaukat Khanum Memorial Cancer Hospital & Research Centre Nov 5, 2026 The Study of Brave-LC LDN Treatment Trial Naloxone, Naltrexone Phase 3 Not yet recruiting National Institute of Allergy and Infectious Diseases (NIAID) Nov 4, 2026 Remote vs. In-Person Study Evaluation (RISE) Trials: RISE Above Opioid Overdose (Trial 3 of 3) Naloxone Not applicable Not yet recruiting State University of New York at Buffalo Oct 15, 2026 A Study of Cebranopadol for Opioid Withdrawal Symptoms in Adults With Chronic Pain Cebranopadol Phase 2 Recruiting Adneuris Therapeutics, Inc. Oct 15, 2026 Medically Supervised Ibogaine With 12-Month Digital Recovery Support for Opioid Use Disorder Naloxone, Naltrexone Phase 1 / Phase 2 Not yet recruiting Clive Michelsen Oct 13, 2026 Idiopathic Pulmonary Fibrosis (IPF)-Related Chronic Cough Reduction With Nalbuphine (NAL) Extended-Release (ER) Tablets Nalbuphine Phase 3 Recruiting Trevi Therapeutics Oct 9, 2026 A Clinical Trial of MK-6916 in Participants With Pain After Bunion Removal Surgery (MK-6916-007) Codeine, Hydrocodone Phase 2 Recruiting Merck Sharp & Dohme LLC Oct 7, 2026 A Pilot Study on the Efficacy of Oral Low Dose Naltrexone for Vulvodynia Naloxone, Naltrexone Phase 2 Not yet recruiting University of Florida Oct 7, 2026 Effect of a Low-Dose Ketamine-Dexmedetomidine-Based Opioid-Sparing Anesthesia Protocol on Postoperative Quality of Recovery After Percutaneous Nephrolithotomy Nalbuphine Phase 4 Not yet recruiting Assiut University Oct 2, 2026 Impact of Entropy Monitoring on Anesthetic Consumption and Recovery After Laparoscopic Cholecystectomy Nalbuphine Not applicable Recruiting KRL Hospital, Islamabad Sep 29, 2026 An Open-Label, Safety and Efficacy Study of Cebranopadol in Participants With Acute Pain With Surgical or Non-Surgical Origin Cebranopadol Phase 3 Recruiting Adneuris Therapeutics, Inc. Sep 28, 2026 Measurement-Based Care to Support Buprenorphine-Naloxone Treatment in Outpatient Addiction Clinics Naloxone Not applicable Not yet recruiting Vanderbilt University Medical Center Sep 24, 2026 Ultrasound-Guided Ilioinguinal-Iliohypogastric Nerve Block Following Spinal Anesthesia Comparing Dexmedetomidine Versus Nalbuphine as Adjuvants to Bupivacaine in Unilateral Inguinal Hernia Repair Nalbuphine Phase 4 Not yet recruiting Assiut University Sep 23, 2026 Comparing Different Medication Regimens to Maintaining Weight Loss Among Adults With Obesity Using GLP-1s Naltrexone Phase 4 Not yet recruiting Jing Luo Sep 21, 2026 Post-Vasectomy Pain Study Codeine Phase 1 Recruiting Columbia University Sep 17, 2026 Nerve Block for Severe Abdominal Pain in the Emergency Department Hydrocodone Early phase 1 Recruiting University of California, Irvine Sep 17, 2026 Suzetrigine in Tonsillectomy for Opioid-sparing Pain Management Codeine Phase 4 Not yet recruiting Stanford University Sep 16, 2026 Abuse Potential of Gabapentin Taken Orally Concomitantly With Oxycodone Hydrochloride in Healthy, Non-Drug-Dependent, Recreational Opioid Users Codeine Phase 4 Recruiting Viatris Inc. Sep 10, 2026 A Clinical Trial of GRT7040 in Adults With Acute Pain Following Bunionectomy Codeine, Hydrocodone Phase 2 Not yet recruiting Grünenthal GmbH Sep 8, 2026 Naloxone for In-Hospital Cardiac Arrest Naloxone Phase 2 / Phase 3 Not yet recruiting Region Skane Sep 8, 2026 A Universal Primary Care Based Intervention to Reduce Youth Overdose Risk Aim 3 Naloxone Not applicable Recruiting Boston Medical Center Sep 1, 2026 Suzetrigine vs. Standard Care Pain Relief Following Outpatient Knee Replacement Surgery Hydrocodone Phase 4 Not yet recruiting Endeavor Health Sep 1, 2026 Pain Control With Ketorolac and Nerve Block After Wrist and Hand Surgery Codeine Phase 4 Recruiting University of Chicago Aug 19, 2026 Afentanil and Remifentanil for Anesthesia Quality and Recovery Nalbuphine Phase 4 Not yet recruiting Qianfoshan Hospital Aug 12, 2026 Interference and Stability Evaluation of the Intelligent Fingerprinting Drug Screening System Codeine Not applicable Enrolling by invitation Intelligent Bio Solutions Inc. Aug 11, 2026 Unilateral Spinal vs General Anaesthesia in Low EF Patients: A Hemodynamic Comparison Nalbuphine — Enrolling by invitation Sargodha Medical College Aug 7, 2026 Pragmatic Trial to Study the Cost-Effectiveness of MyPhenome-RX Test to Guide Anti-Obesity Pharmacotherapy Naltrexone Not applicable Not yet recruiting Phenomix Sciences Jul 27, 2026 Clinician Practice Companion to Address Youth Substance Use Naloxone Not applicable Not yet recruiting Massachusetts General Hospital Jul 24, 2026 The Effect of Nalbuphine Extended-Release (NAL ER) on Cough in Participants With Refractory Chronic Cough (RCC) Nalbuphine Phase 2 Recruiting Trevi Therapeutics Jun 26, 2026 Naltrexone for Nonsuicidal Self-Injury Naltrexone Not applicable Not yet recruiting Seoul National University Hospital Jun 11, 2026 Suzetrigine vs Norco-postoperative Mohs Pain Hydrocodone Phase 4 Enrolling by invitation Baylor Research Institute May 8, 2026 Cold and Compression After Rotator Cuff Repair (RCR) Hydrocodone Not applicable Recruiting Ochsner Health System Apr 8, 2026 Evaluate the Efficacy and Safety of Naltrexone Hydrochloride Implant in Patients With Alcohol Use Disorder Naltrexone Phase 3 Not yet recruiting Shenzhen Sciencare Medical Industries Co., Ltd. Feb 25, 2026 Neurophysiological Effects of Medication Tapering During Treatment With Spinal Cord Stimulation Oxymorphone — Recruiting Brai²n Feb 17, 2026 A Multiple Health Behavior Change (MHBC) Intervention for Weight Loss and Smoking Cessation for Pre-Bariatric Surgery Patients Naltrexone Phase 1 / Phase 2 Not yet recruiting Medical University of South Carolina Feb 9, 2026 An Artificial Intelligence Driven Approach to Optimize Patient Selection for a Transitional Pain Service Hydrocodone Phase 3 Not yet recruiting University of California, San Francisco Dec 22, 2025 RCT: Suzetrigine vs Norco for Post-op Pain Hydrocodone Phase 4 Not yet recruiting Jacob Lensing Sep 29, 2025 Determining the Effect of Abiraterone on the Metabolism of Oxycodone in Men With Prostate Cancer (the ENABLE Study) Oxymorphone Phase 4 Recruiting Deventer Ziekenhuis Jun 3, 2025 Project 1 Aim 2, Adaptations of the Brain in Chronic Pain With Opioid Exposure Oxymorphone Phase 2 Active, not recruiting Northwestern University Jul 19, 2022
Show all 40Drugs, mechanisms, furthest stage (max phase) and modality (molecule type) are from ChEMBL CHEMBL2095181 , ChEMBL 37, fetched 2026-11-18 (CC BY-SA 3.0). Sponsors are the US application holder (Drugs@FDA) for approved drugs with a US page, else the industry lead sponsor of the most of the drug's ClinicalTrials.gov trials. Open trials are recruiting or ongoing studies naming the drug as an intervention on ClinicalTrials.gov , checked daily; this page as of 2026-11-21. ChEMBL and Open Targets